Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Programs; 3-Year AI Antidote Development Model

Ripple-backed XRP treasury firm eyes Nasdaq debut with $1B plan

Wall Street falls as oil surge stokes inflation fears; Russell 2000 slips

It's called 'private credit' — and it could lead to big trouble on Wall Street

U.S. stocks have reached a critical line in the sand. Why the next move could be a 10% drop.

Stocks recover from war shock as Wall Street sniffs a turning point